ALQ Gold Corp. (CSE: ALQ) (“ALQ” or the “Company”) is pleased to announce the following developments:
1. the Company has entered into a binding letter of intent with Vulcan Enterprises Ltd. (“Vulcan”) to acquire certain intellectual property rights for use of the name, approved photographs, approved images, voice, and approved likenesses of Dan Bilzerian exclusively within the cannabis industry worldwide (collectively, “Licensed IP”);
2. the Company has completed its second investment, being the acquisition of 100,000 units in the capital of Salvation Botanicals Ltd. (“Salvation”) for $500,000;
3. the Company has arranged a non-brokered private placement to raise up to $10,000,000 through the distribution of 10 million units of the Company at a price of $1.00 per unit. Each unit will comprise one common share (“Shares”) and one-half of one share purchase warrant (“Warrants”), each whole Warrant entitling the holder to acquire one additional Share at $2.50 for a period of 12 months; and
4. the Company intends to change its name to Green Axis Capital Corp. and become an investment company focusing on opportunities in the global cannabis sector.
About Vulcan Enterprises Ltd.
Vulcan is the exclusive owner of the Licensed IP, which includes the cannabis brand logos or related marks, including “Burn by Bilzerian” and “Ignite by Bilzerian”. ALQ and Vulcan have agreed to the following:
i. ALQ will receive initially a limited license to utilize the Licensed IP for its use in the Canadian cannabis industry, in exchange for ALQ issuing 5,000,000 shares to Vulcan;
ii. Vulcan will assist with ALQ’s utilization of the Licensed IP through personal appearance by Dan Bilzerian and utilization of Dan Bilzerian’s social media accounts; and
iii. ALQ will retain the exclusive option to acquire additional global and exclusive rights to Vulcan’s Licensed IP for additional consideration.
Closing of the above transactions is conditional upon closing of an equity financing by ALQ of at least $10,000,000 (see item 3 above for details of the proposed financing).
About Salvation Botanicals Ltd.
Salvation is a private British Columbia company based in Nanaimo, which is involved in the production of high quality standardized cannabinoid products for Licensed Producers (LP’s), and operates one of the first analytics laboratories in Canada, accredited by Health Canada to test cannabis and derivatives for LP’s, Access to Cannabis for Medical Purposes Regulations (ACMPR) growers, approved cannabis patients, Section 56 License holders, industrial hemp producers, and any other party legally entitled to possess cannabis.
Salvation holds a Narcotic Dealer’s Licence, allowing contract extract production, with authority to extract and produce oil, capsules and tinctures within Health Canada guidelines. In 2016 Health Canada granted Salvation a Hemp Processing License (HPL) permitting production and sale of seed & grain derivatives. Using the name “Purely Hemp” Salvation has developed a line of value-added foods including Hemp Protein Powder, Hulled Hemp Seeds, Protein Bars, Hemp Butter, Capsules (Oil, Protein Powder) and Cold-Pressed Hemp Oil while building exports of value-added bulk hemp products.
It is planned that Salvation will produce certain products on behalf of Vulcan and ALQ to bring Dan Bilzerian’s brands to market in Canada in time for the launch of recreational sales and other global jurisdictions that have legal medical marijuana legislation and suitable import laws.
ON BEHALF OF THE BOARD
“Morgan Good”
Chief Executive Officer
Tel: 604-715-4751
Email: morgan@dukecapitalinc.com
Investor Contact:
Keir Reynolds
Duke Capital
Tel: 778-998-9242
Email: keir@dukecapitalinc.com
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to: the terms and conditions of the proposed transaction; the terms and conditions of the proposed private placement; use of funds; and the business and operations of the Company after the proposed change of business. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; delay or failure to receive board, shareholder or regulatory approvals; and the uncertainties surrounding the cannabis industry in North America. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. ALQ disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Source: www.stockwatch.com


Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less